Randomised Comparison of a Novel Buprenorphine Oral Lyophilisate versus Existing Buprenorphine Sublingual Tablets in Opioid-Dependent Patients: A First-in-Patient Phase II Randomised Open Label Safety Study

Publisher： Karger

E-ISSN： 1421-9891|23|2|61-70

ISSN： 1022-6877

Source： European Addiction Research, Vol.23, Iss.2, 2017-03, pp. : 61-70

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of steroidal vs non-steroidal agents in oral lichen planus: a randomised, open-label study

By  

Journal of Laryngology and Otology, Vol. 131, Iss. 1, 2017-01 ,pp. : 69-76

Cambridge University Press

Access to resources Recommend Favorite

Comparison of Buprenorphine and Methadone in the Treatment of Opioid Dependence

By  

European Addiction Research, Vol. 4, Iss. 1, 1998-10 ,pp. : 13-18

Karger

Access to resources Recommend Favorite

Conversion from High‐Dose Full‐Opioid Agonists to Sublingual Buprenorphine Reduces Pain Scores and Improves Quality of Life for Chronic Pain Patients

By  

PAIN MEDICINE, Vol. 15, Iss. 12, 2014-12 ,pp. : 2087-2094

John Wiley & Sons Inc

Access to resources Recommend Favorite

A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial

By Mercadante S.   Radbruch L.   Davies A.   Poulain P.   Sitte T.   Perkins P.   Colberg T.   Camba M.A.  

Current Medical Research and Opinion, Vol. 25, Iss. 11, 2009-11 ,pp. : 2805-2815

Informa Healthcare

Access to resources Recommend Favorite

Effects of oral nutritional supplementation in the management of malnutrition in hospital and post‐hospital discharged patients in India: a randomised, open‐label, controlled trial

By  

JOURNAL OF HUMAN NUTRITION & DIETETICS (ELECTRONIC), Vol. 28, Iss. 4, 2015-08 ,pp. : 331-343

John Wiley & Sons Inc

Access to resources Recommend Favorite